Page last updated: 2024-09-05

sorafenib and dimethyl sulfoxide

sorafenib has been researched along with dimethyl sulfoxide in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (dimethyl sulfoxide)	Trials (dimethyl sulfoxide)	Recent Studies (post-2010) (dimethyl sulfoxide)
6,520	730	5,251	15,763	292	3,388

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Busch, S; Garbe, C; Herlyn, M; Kulms, D; Lasithiotakis, K; Maczey, E; Meier, F; Schittek, B	1

Other Studies

1 other study(ies) available for sorafenib and dimethyl sulfoxide

Article	Year
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. The British journal of dermatology, 2007, Volume: 156, Issue:6 Topics: Androstadienes; Apoptosis; Benzenesulfonates; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Humans; MAP Kinase Signaling System; Melanoma; Neoplasm Invasiveness; Neoplasm Proteins; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; Sorafenib; Wortmannin	2007

Article

Year

Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment.

The British journal of dermatology, 2007, Volume: 156, Issue:6

Topics: Androstadienes; Apoptosis; Benzenesulfonates; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Humans; MAP Kinase Signaling System; Melanoma; Neoplasm Invasiveness; Neoplasm Proteins; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; Sorafenib; Wortmannin

2007